Interferon Alfa has 9 known drug interactions based on U.S. FDA drug labeling data. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Abacavir , Lamivudine And Zidovudine, Lamivudine And Zidovudine, Zidovudine. Patients taking Interferon Alfa should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 9
- Major
- 3
- Minor
- 6
Major (3)
- Interferon Alfa + Abacavir , Lamivudine And Zidovudine— Coadministration may increase hematologic toxicity of zidovudine.
- Interferon Alfa + Lamivudine And Zidovudine— May increase hematologic toxicity of zidovudine and increase risk of hepatic decompensation (some fatal) in HIV-1/HCV co…
- Interferon Alfa + Zidovudine— Coadministration may increase the hematologic toxicity of zidovudine.
Minor (6)
- Interferon Alfa + Bevacizumab— No clinically meaningful effect on pharmacokinetics of interferon alfa when administered with bevacizumab.
- Interferon Alfa + Bevacizumab-Adcd— No clinically meaningful effect on pharmacokinetics of interferon alfa when administered with bevacizumab.
- Interferon Alfa + Bevacizumab-Awwb— No clinically meaningful effect on interferon-alfa pharmacokinetics observed when administered with bevacizumab.
- Interferon Alfa + Bevacizumab-Bvzr— No clinically meaningful effect on interferon alfa pharmacokinetics observed when bevacizumab was administered in combin…
- Interferon Alfa + Bevacizumab-Maly— No clinically meaningful effect on the pharmacokinetics of interferon alfa observed when bevacizumab was administered in…
- Interferon Alfa + Bevacizumab-Nwgd— No clinically meaningful effect on the pharmacokinetics of interferon alfa when bevacizumab was administered in combinat…